title: Commentary: In search of answers regarding the benefits and harms of short term ADT for intermediate-risk prostate cancer.
authors.affiliation: Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
authors.forename: Timothy N
authors.initials: TN
authors.lastname: Showalter
mesh_terms: D000726:Androgen Antagonists; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms
chemical_list: D000726:Androgen Antagonists